
Ilgin Arslan, MSc
Researcher Learning Health System
Research
I am involved in the Formulary-based Prescribing project within the Learning Health System research program. This project focuses on stimulating the efficient prescription of medicines within general practice. Data from the GP information system are used for this purpose.
I find it important that scientific research has a socially relevant contribution. I also find it important to approach research from different perspectives, so that research results are relevant and useful for all stakeholders in healthcare. I get excited about looking for opportunities to use healthcare data as optimally as possible for research purposes. To achieve this as efficiently as possible, I enjoy collaborating with different parties.
I find it important that scientific research has a socially relevant contribution. I also find it important to approach research from different perspectives, so that research results are relevant and useful for all stakeholders in healthcare. I get excited about looking for opportunities to use healthcare data as optimally as possible for research purposes. To achieve this as efficiently as possible, I enjoy collaborating with different parties.
Publications
- 2023|Dros, J.T., Dijk, C.E. van, Bos, I., Meijer, W.M., Chorus, A., Miedema, H., Veenhof, C., Arslan, I.G., Meijboom, B.R., Verheij, R.A. Healthcare utilization patterns for knee or hip osteoarthritis before and after changes in national health insurance coverage: a data linkage study. Health Policy: 2023, 133, Art. nr. 104825
- 2022|Arslan, I.G. Knee and hip osteoarthritis in general practice: incidence, prevalence and efforts to optimize care=Knie- en heupartrose in de huisartspraktijk: Incidentie, prevalentie en inzet om de zorg te optimaliseren. Rotterdam: Erasmus Universiteit MC, 2022.
- 2022|Arslan, I., Ramerman, L., Hek, K., Meijer, A., Lambooij, A., Verheij, R. Formulariumgericht Voorschrijven door de huisarts: doorontwikkeling indicatoren en monitoring 2019-2021. Utrecht: Nivel, 2022.